Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Anticonvulsants market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Anticonvulsants market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Anticonvulsants market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Anticonvulsants products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Anticonvulsants products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Anticonvulsants market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Anticonvulsants development has been the leading industry trend of Anticonvulsants market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Anticonvulsants Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Epilepsy, Fibromyalgia, Migraine, Neuropathic pain, Bipolar disorder, Anxiety, Borderline personality disorder |
| By Application Outlook |
Hospital, Clinic, Home Care, Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Johnson & Johnson (J&J), Novartis AG, UCB Group, GlaxoSmithKline plc., Pfizer Inc., Abbott Laboratories, Cephalon Inc., Shire plc. |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- Johnson & Johnson (J&J)
- Novartis AG
- UCB Group
- GlaxoSmithKline plc.
- Pfizer Inc.
- Abbott Laboratories
- Cephalon Inc.
- Shire plc.
Anticonvulsants Market, By Type
- Epilepsy
- Fibromyalgia
- Migraine
- Neuropathic pain
- Bipolar disorder
- Anxiety
- Borderline personality disorder
Anticonvulsants Market, By Application
- Hospital
- Clinic
- Home Care
- Other
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table of Contents
1 Study Coverage
1.1 Anticonvulsants Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Anticonvulsants Market Size Growth Rate by Product
1.4.2 Epilepsy
1.4.3 Fibromyalgia
1.4.4 Migraine
1.4.5 Neuropathic pain
1.4.6 Bipolar disorder
1.4.7 Anxiety
1.4.8 Borderline personality disorder
1.5 Market by End User
1.5.1 Global Anticonvulsants Market Size Growth Rate by End User
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Home Care
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Anticonvulsants Market Size
2.1.1 Global Anticonvulsants Revenue 2017-2027
2.1.2 Global Anticonvulsants Sales 2017-2027
2.2 Anticonvulsants Growth Rate by Regions
2.2.1 Global Anticonvulsants Sales by Regions
2.2.2 Global Anticonvulsants Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Anticonvulsants Sales by Manufacturers
3.1.1 Anticonvulsants Sales by Manufacturers
3.1.2 Anticonvulsants Sales Market Share by Manufacturers
3.1.3 Global Anticonvulsants Market Concentration Ratio (CR5 and HHI)
3.2 Anticonvulsants Revenue by Manufacturers
3.2.1 Anticonvulsants Revenue by Manufacturers (2017-2020)
3.2.2 Anticonvulsants Revenue Share by Manufacturers (2017-2020)
3.3 Anticonvulsants Price by Manufacturers
3.4 Anticonvulsants Manufacturing Base Distribution, Product Types
3.4.1 Anticonvulsants Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anticonvulsants Product Type
3.4.3 Date of International Manufacturers Enter into Anticonvulsants Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Anticonvulsants Sales by Product
4.2 Global Anticonvulsants Revenue by Product
4.3 Anticonvulsants Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Anticonvulsants Breakdown Data by End User
6 North America
6.1 North America Anticonvulsants by Countries
6.1.1 North America Anticonvulsants Sales by Countries
6.1.2 North America Anticonvulsants Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Anticonvulsants by Product
6.3 North America Anticonvulsants by End User
7 Europe
7.1 Europe Anticonvulsants by Countries
7.1.1 Europe Anticonvulsants Sales by Countries
7.1.2 Europe Anticonvulsants Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Anticonvulsants by Product
7.3 Europe Anticonvulsants by End User
8 Asia Pacific
8.1 Asia Pacific Anticonvulsants by Countries
8.1.1 Asia Pacific Anticonvulsants Sales by Countries
8.1.2 Asia Pacific Anticonvulsants Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Anticonvulsants by Product
8.3 Asia Pacific Anticonvulsants by End User
9 Central & South America
9.1 Central & South America Anticonvulsants by Countries
9.1.1 Central & South America Anticonvulsants Sales by Countries
9.1.2 Central & South America Anticonvulsants Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Anticonvulsants by Product
9.3 Central & South America Anticonvulsants by End User
10 Middle East and Africa
10.1 Middle East and Africa Anticonvulsants by Countries
10.1.1 Middle East and Africa Anticonvulsants Sales by Countries
10.1.2 Middle East and Africa Anticonvulsants Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Anticonvulsants by Product
10.3 Middle East and Africa Anticonvulsants by End User
11 Company Profiles
11.1 Johnson & Johnson (J&J)
11.1.1 Johnson & Johnson (J&J) Company Details
11.1.2 Company Business Overview
11.1.3 Johnson & Johnson (J&J) Anticonvulsants Sales, Revenue and Gross Margin (2017-2020)
11.1.4 Johnson & Johnson (J&J) Anticonvulsants Products Offered
11.1.5 Johnson & Johnson (J&J) Recent Development
11.2 Novartis AG
11.2.1 Novartis AG Company Details
11.2.2 Company Business Overview
11.2.3 Novartis AG Anticonvulsants Sales, Revenue and Gross Margin (2017-2020)
11.2.4 Novartis AG Anticonvulsants Products Offered
11.2.5 Novartis AG Recent Development
11.3 UCB Group
11.3.1 UCB Group Company Details
11.3.2 Company Business Overview
11.3.3 UCB Group Anticonvulsants Sales, Revenue and Gross Margin (2017-2020)
11.3.4 UCB Group Anticonvulsants Products Offered
11.3.5 UCB Group Recent Development
11.4 GlaxoSmithKline plc.
11.4.1 GlaxoSmithKline plc. Company Details
11.4.2 Company Business Overview
11.4.3 GlaxoSmithKline plc. Anticonvulsants Sales, Revenue and Gross Margin (2017-2020)
11.4.4 GlaxoSmithKline plc. Anticonvulsants Products Offered
11.4.5 GlaxoSmithKline plc. Recent Development
11.5 Pfizer Inc.
11.5.1 Pfizer Inc. Company Details
11.5.2 Company Business Overview
11.5.3 Pfizer Inc. Anticonvulsants Sales, Revenue and Gross Margin (2017-2020)
11.5.4 Pfizer Inc. Anticonvulsants Products Offered
11.5.5 Pfizer Inc. Recent Development
11.6 Abbott Laboratories
11.6.1 Abbott Laboratories Company Details
11.6.2 Company Business Overview
11.6.3 Abbott Laboratories Anticonvulsants Sales, Revenue and Gross Margin (2017-2020)
11.6.4 Abbott Laboratories Anticonvulsants Products Offered
11.6.5 Abbott Laboratories Recent Development
11.7 Cephalon Inc.
11.7.1 Cephalon Inc. Company Details
11.7.2 Company Business Overview
11.7.3 Cephalon Inc. Anticonvulsants Sales, Revenue and Gross Margin (2017-2020)
11.7.4 Cephalon Inc. Anticonvulsants Products Offered
11.7.5 Cephalon Inc. Recent Development
11.8 Shire plc.
11.8.1 Shire plc. Company Details
11.8.2 Company Business Overview
11.8.3 Shire plc. Anticonvulsants Sales, Revenue and Gross Margin (2017-2020)
11.8.4 Shire plc. Anticonvulsants Products Offered
11.8.5 Shire plc. Recent Development
12 Future Forecast
12.1 Anticonvulsants Market Forecast by Regions
12.1.1 Global Anticonvulsants Sales Forecast by Regions 2021-2027
12.1.2 Global Anticonvulsants Revenue Forecast by Regions 2021-2027
12.2 Anticonvulsants Market Forecast by Product
12.2.1 Global Anticonvulsants Sales Forecast by Product 2021-2027
12.2.2 Global Anticonvulsants Revenue Forecast by Product 2021-2027
12.3 Anticonvulsants Market Forecast by End User
12.4 North America Anticonvulsants Forecast
12.5 Europe Anticonvulsants Forecast
12.6 Asia Pacific Anticonvulsants Forecast
12.7 Central & South America Anticonvulsants Forecast
12.8 Middle East and Africa Anticonvulsants Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Anticonvulsants Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
